NR4A1 and breast carcinoma: Previous studies in breast cancer (Vazquez et al. 2016; González-Reymúndez et al. 2017) showed a relevant proportion of variation associated to methylation but 33% lower than gene expression, which has shown patterns that can be clustered in tumor subtypes (Perou et al. 2000; e.g., absence or presence of hormone receptors).